Therefore, in theory, inhibition of L1CAM can not only suppress VC by preventing cancer cells motility and adhesion but also increase the efficacy of chemotherapy or immunotherapy inducing vascular normalization (82, 94). The gene discussed is L1CAM; the disease is cancer.